DUSA Pharmaceuticals, Inc. (DUSA) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $57.68 --0%
Financial Fact:
Cost of product revenues: 1.51M
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Cost of product revenues: 1.51M
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA) reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $13.84 million.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
